引用本文:[点击复制]
[点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 28次   下载 9 本文二维码信息
码上扫一扫!
SGLT2抑制剂对心力衰竭的影响
路晨阳,贺秀,景娜,刘永铭
0
(兰州大学第一临床医学院·兰州大学第一医院老年心血管病科)
摘要:
【摘要】 糖尿病患者更易发生心力衰竭,伴随糖尿病的心力衰竭患者预后更差。目前已有的多种降糖药物对合并糖尿病的心衰患者治疗效果欠佳,有的甚至有害。SGLT2抑制剂是一种新型降糖药,在多项临床研究中发现其对心血管有保护作用。本文就SGLT2抑制剂对心力衰竭的影响做一综述。
关键词:  SGLT2抑制剂  心力衰竭  糖尿病
DOI:
基金项目:国家临床重点专科建设项目(2013—240)
The effect of SGLT2 inhibitors on heart failure
LU Chenyang,HE Xiu,JING Na,LIU Yongming
(Department of Geriatrics Cardiology, The First Clinical Medical College of Lanzhou University, The First Hospital of Lanzhou University)
Abstract:
【Abstract】 A large number of studies have found that patients with diabetes are more likely to have heart failure, heart failure patients with diabetes usually have poorer prognosis, so that heart failure is a very important health problem in elderly diabetics in China. Currently, many kinds of hypoglycemic drugs on the market have poor therapeutic effect on heart failure patients with diabetes, some drugs are even harmful. Cardiovascular protective effect of SGLT2 inhibitors was observed in several clinical studies. In this paper, we are going to summarize the effect of SGLT2 inhibitors on heart failure.
Key words:  SGLT2 inhibitors  Heart failure  Diabetes mellitus

用微信扫一扫

用微信扫一扫